Vascular Biogenics Ltd
VBLT - NASDAQ
Overview
Dividend safety
Dividends
Fundamentals
Add to watchlist
Add to calculator
Compare stock
Vascular Biogenics Ltd
VBLT
-NASDAQ
Overview
Create a free account to get access to stock details and our dividend tracker
We won't send you any spam and we don't want a credit card.
About stock
Health care
Sector
Biotechnology
Industry
Vascular Biogenics Ltd., a biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. It develops VB-601 using monocyte targeting technology for various inflammatory indications. The company was formerly known as Medicard Ltd. and changed its name to Vascular Biogenics Ltd. in January 2003.
Vascular Biogenics Ltd. was incorporated in 2000 and is headquartered in Modi'in, Israel.
Similar stocks
Based on sector and market capitalization
Report issue